What Happened?
New York, NY-based Bristol-Myers-Squibb Resigned Matthew Hagan as Executive Director of Hematology Portfolio Marketing
About the Company
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. Through the Bristol-Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world`s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.
About the Person
Matthew Hagan is Vice President of Marketing and Strategic Alliances at Cellectar. Previously, Matthew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile